The incidence of postoperative re-stratification for recurrence in well-differentiated thyroid cancer-a retrospective cohort study

被引:2
|
作者
Neiderman, Narin N. Carmel [1 ]
Duek, Irit [1 ]
Ravia, Adi [1 ]
Yaka, Ronel [1 ]
Warshavsky, Anton [1 ]
Ringel, Barak [1 ]
Muhanna, Nidal [1 ]
Horowitz, Gilad [1 ]
Baran, Tomer Ziv [2 ]
Fliss, Dan M. [1 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Tel Aviv Sourasky Med Ctr, Dept Otolaryngol Head & Neck,Maxillofacial Surg, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel
关键词
Low risk; risk stratification; partial thyroidectomy; hemi-thyroidectomy (HT); completion thyroidectomy; ASSOCIATION MANAGEMENT GUIDELINES; LOW-RISK; HORMONE REPLACEMENT; ADULT PATIENTS; PAPILLARY; CARCINOMA; EXTENT; LOBECTOMY; SURVIVAL; FEATURES;
D O I
10.21037/gs-21-105
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: After diagnosing well-differentiated thyroid cancer (WDTC), assessment of the risk for disease-specific recurrence is essential for deciding between hemi-thyroidectomy (HT) and total thyroidectomy (TT). The American Thyroid Association (ATA) 2015 guidelines suggest that patients with 1-4 cm WDTC without suspicious features may be suitable for HT. Patients' preoperatively determined risk levels are re-stratified according to surgical and final histopathological findings. The incidence and clinical implications of high-risk features discovered postoperatively in patients with preoperatively determined low-risk WDTC are yet to be better defined. Methods: Thyroidectomies performed in the Tel-Aviv Sourasky Medical Center (TASMC) [2006-2018] were included. Patients with 1-4 cm WDTC without evidence of positive cervical lymph nodes, invasion to adjacent structures, or high-risk cytology were considered at low risk for disease-specific recurrence-suitable for lobectomy. Patients were stratified according to their risk for disease-specific recurrence, pre- and postoperatively, and the rate of completion thyroidectomy was determined. Results: In total, 301 (21%) patients were preoperatively stratified as low risk. Forty-six of them (15%) were re-stratified postoperatively as intermediate-to-high-risk. There were no significant differences in the characteristics of the patients who maintained their original stratification to patients who were upscaled to a higher risk level postoperatively. Conclusions: We report a 15% rate of postoperative risk escalation of patients who required completion thyroidectomy according to current ATA guidelines. In our opinion, this rate of postoperative WDTC upscaling of risk requiring more radical surgery than originally planned, is acceptable. Meticulous preoperative personalized evaluation by an experienced multidisciplinary dedicated team is essential.
引用
收藏
页码:2354 / 2367
页数:14
相关论文
共 50 条
  • [41] Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
    Lin, Yaobin
    Liu, Shan
    Hong, Liang
    Shao, Lingdong
    Wu, Junxin
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [42] Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years
    Kropinska, Aleksandra
    Ledwon, Aleksandra
    Cieslik, Ewa Paliczka
    Olczyk, Tomasz
    Blewaska, Aleksandra
    Krzempek, Marcela
    Wilk, Agata
    Cortez, Alexander
    Czarniecka, Agnieszka
    Jarzab, Barbara
    Junak, Daria Handkiewicz
    THYROID, 2024, 34 (10) : 1234 - 1245
  • [43] Evaluation of the usefulness of positron emission tomography with [18F]fluorodeoxylglucose performed to detect non-radioiodine avid recurrence and/or metastasis of differentiated thyroid cancer-a preliminary study
    Kolodziej, Maciej
    Saracyn, Marek
    Lubas, Arkadiusz
    Brodowska-Kania, Dorota
    Mazurek, Andrzej
    Dziuk, Miroslaw
    Dymus, Jolanta
    Kaminski, Grzegorz
    NUCLEAR MEDICINE REVIEW, 2021, 24 (02) : 63 - 69
  • [44] Prognostic Impact of Direct 131I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study
    Carrillo, Jose F.
    Vazquez-Romo, Rafael
    Ramirez-Ortega, Margarita C.
    Carrillo, Liliana C.
    Gomez-Argumosa, Edgar
    Onate-Ocana, Luis F.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [45] Effect of thyrotropin suppressive therapy on lumbar bone mineral density in patients with differentiated thyroid cancer: a retrospective cohort study
    Wang, Xinshui
    Teng, Ruoling
    Liu, Fenfen
    Liu, Ping
    Yang, Yujiao
    GLAND SURGERY, 2022, 11 (02) : 432 - 441
  • [46] Access to diagnostic imaging and incidental detection of differentiated thyroid cancer in Ontario: A population-based retrospective cohort study
    Norwood, Todd A.
    Rosella, Laura C.
    Buajitti, Emmalin
    Lipscombe, Lorraine L.
    Stukel, Therese A.
    SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY, 2022, 43
  • [47] Impact of American Thyroid Association's Revised Cancer Management Guidelines on Thyroid Cancer Incidence Trends: A Retrospective Cohort Study, 2000-2020
    Fwelo, Pierre
    Heredia, Natalia I.
    Li, Ruosha
    Bangolo, Ayrton
    Nagesh, Vignesh K.
    Weissman, Simcha
    Du, Xianglin L.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [48] Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
    Yaobin Lin
    Shan Liu
    Liang Hong
    Lingdong Shao
    Junxin Wu
    Radiation Oncology, 17
  • [49] Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study
    de Castro, Taciana Padilha
    Waissmann, William
    Simoes, Taynana Cesar
    de Mello, Rossana Corbo R.
    Carvalho, Denise P.
    CLINICAL ENDOCRINOLOGY, 2016, 85 (03) : 466 - 474
  • [50] Effects of Implementation of European Thyroid Imaging Reporting and Data System Risk Stratification fi cation in a Thyroid Cancer Program in Western Sweden: A Retrospective Cohort Study
    Dahlberg, Jakob
    Carlqvist, Jeanette
    Larsson, Emma
    Nilsson, Mikael
    Elias, Erik
    Muth, Andreas
    ENDOCRINE PRACTICE, 2024, 30 (09) : 830 - 836